tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Novartis AG

NVS
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
152.900USD
+3.970+2.67%
์‹œ์žฅ ์šด์˜ ์‹œ๊ฐ„ย ๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
293.38B์‹œ๊ฐ€์ด์•ก
21.76P/E TTM
์ƒ์„ธ ์ฐจํŠธ ๋ณด๊ธฐ
TradingKey ๅ›พ่กจ
Intraday
1m
30m
1h
D
W
M
D

์˜ค๋Š˜

+2.67%

5์ผ

+0.88%

1๊ฐœ์›”

+0.59%

6๊ฐœ์›”

+11.71%

์˜ฌํ•ด ํ˜„์žฌ๊นŒ์ง€

+10.90%

1๋…„

+32.07%

ํ•ต์‹ฌ ์ˆ˜์น˜
151.950์‹œ๊ฐ€
153.120์ตœ๊ณ ๊ฐ€
1.07M๊ฑฐ๋ž˜๋Ÿ‰
21.76P/E TTM
16.19๋™์  P/E ๋น„์œจ
3.081๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.06%ํšŒ์ „์œจ
148.930์ „์ผ ์ข…๊ฐ€
151.355์ตœ์ €๊ฐ€
96.07M๋งค์ถœ์•ก
24.57์ฃผ๊ฐ€์ˆ˜์ต๋น„์œจ
6.62P/B
2.02%๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
12.37%ROA
170.46052์ฃผ ์ตœ๊ณ ๊ฐ€
0.70๊ฑฐ๋ž˜๋Ÿ‰ ๋น„์œจ
11.94B์ˆœ์ด์ต
1.92B์ฃผ์‹
7.0268์ฃผ๋‹น์ˆœ์ด์ต
0.47๋ฒ ํƒ€
35.21%ROE
111.06052์ฃผ ์ตœ์ €๊ฐ€
1.19%๋ณ€๋™ ํญ
74.55%์ด ์ด์ต๋ฅ 
293.38B์‹œ๊ฐ€์ด์•ก
-2.15๋ณด์ƒ/์œ„ํ—˜
0.87%์œ„ํ—˜๋ฅ 

TradingKey Novartis AG ์ฃผ์‹ ์ ์ˆ˜๎˜

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2026-06-22

์ฃผ์š” ์ธ์‚ฌ์ดํŠธ

Novartis AG์˜ ํŽ€๋”๋ฉ˜ํ„ธ์€ ๋น„๊ต์  ์•ˆ์ •์  ์ƒํƒœ์ด๋ฉฐ, ์„ฑ์žฅ ์ž ์žฌ๋ ฅ์€ ๋†’์Šต๋‹ˆ๋‹ค.๊ธฐ์—…์˜ ๋ฐธ๋ฅ˜์—์ด์…˜์€ ์ ์ •ํ•˜๊ฒŒ ํ‰๊ฐ€๋œ ๊ฒƒ์œผ๋กœ ๊ฐ„์ฃผ๋˜๋ฉฐ, ์ œ์•ฝ ์‚ฐ์—…์—์„œ 157๊ฐœ ์ค‘ 64์œ„ ๋žญํ‚น.๊ธฐ๊ด€ ๋ณด์œ  ๋น„์œจ์€ ๋งค์šฐ ๋†’์€.์ง€๋‚œ ํ•œ ๋‹ฌ ๋™์•ˆ ์—ฌ๋Ÿฌ ์• ๋„๋ฆฌ์ŠคํŠธ๊ฐ€ ํ•ด๋‹น ๊ธฐ์—…์„ ๋ณด์œ (์œผ)๋กœ ํ‰๊ฐ€ํ–ˆ์œผ๋ฉฐ, ์ตœ๊ณ  ๋ชฉํ‘œ ๊ฐ€๊ฒฉ์€ 143.65์ž…๋‹ˆ๋‹ค.์ค‘๊ธฐ์ ์œผ๋กœ ์ฃผ๊ฐ€๋Š” ์•ˆ์ •์ ์ธ ์ƒํƒœ๋ฅผ ์œ ์ง€ํ•  ๊ฒƒ์œผ๋กœ ์˜ˆ์ƒ๋ฉ๋‹ˆ๋‹ค.์ง€๋‚œ ํ•œ ๋‹ฌ๊ฐ„ ์ฃผ์‹ ์‹œ์žฅ์—์„œ ํ‰๋ฒ”ํ•œ ์„ฑ๊ณผ๋ฅผ ๊ฑฐ๋‘์—ˆ์ง€๋งŒ, ๊ธฐ์—…์˜ ํŽ€๋”๋ฉ˜ํ„ธ๊ณผ ๊ธฐ์ˆ ์  ์ง€ํ‘œ๋Š” ํƒ„ํƒ„ํ•ฉ๋‹ˆ๋‹ค.์ฃผ๊ฐ€๋Š” ์ง€์ง€์„ ๊ณผ ์ €ํ•ญ์„  ์‚ฌ์ด์—์„œ ํšก๋ณดํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ๋ฒ”์œ„ ๋งค๋งค ๊ธฐ๋ฐ˜์˜ ์Šค์œ™ ํŠธ๋ ˆ์ด๋”ฉ์— ์ ํ•ฉํ•œ ์ƒํ™ฉ์ž…๋‹ˆ๋‹ค.

Novartis AG ์ ์ˆ˜๎˜ฐ๎˜ฐ

๊ด€๋ จ ์ •๋ณด

์‚ฐ์—… ์ˆœ์œ„
64 / 157
์ „์ฒด ์ˆœ์œ„
160 / 4577
์‚ฐ์—…
์ œ์•ฝ

์ €ํ•ญ์„  & ์ง€์ง€์„ 

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

๋ ˆ์ด๋” ์ฐจํŠธ

ํ˜„์žฌ ๊ฐ€๊ฒฉ
๊ณผ๊ฑฐ

๋ฏธ๋””์–ด ๋ณด๋„

์ตœ๊ทผ 24 ์‹œ๊ฐ„
๋ณด๋„ ์ˆ˜์ค€

๋งค์šฐ ๋‚ฎ์€
๋งค์šฐ ๋†’์€
์ค‘๋ฆฝ

Novartis AG ์ฃผ์š” ๋‚ด์šฉ

๊ฐ•์ ์œ„ํ—˜ ์š”์†Œ
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
๋†’์€ ์„ฑ์žฅ
ํšŒ์‚ฌ์˜ ๋งค์ถœ์€ ์ง€๋‚œ 3๋…„๊ฐ„ ๊พธ์ค€ํžˆ ์„ฑ์žฅํ•ด์™”์œผ๋ฉฐ, ์—ฐํ‰๊ท  20.72%์˜ ์ฆ๊ฐ€์œจ์„ ๊ธฐ๋กํ–ˆ์Šต๋‹ˆ๋‹ค.
๋†’์€ ๋ฐฐ๋‹น๊ธˆ
ํšŒ์‚ฌ๋Š” ๋†’์€ ๋ฐฐ๋‹น๊ธˆ์„ ์ง€๊ธ‰ํ•˜๋Š” ํšŒ์‚ฌ๋กœ, ์ตœ์‹  ๋ฐฐ๋‹น๊ธˆ ์ง€๊ธ‰ ๋น„์œจ์€ 68.10%์ž…๋‹ˆ๋‹ค.
์•ˆ์ •์ ์ธ ๋ฐฐ๋‹น๊ธˆ
ํšŒ์‚ฌ๋Š” ์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ •๊ธฐ์ ์œผ๋กœ ๋ฐฐ๋‹น๊ธˆ์„ ์ง€๊ธ‰ํ•˜์˜€์œผ๋ฉฐ, ์ตœ์‹  ๋ฐฐ๋‹น๊ธˆ ์ง€๊ธ‰ ๋น„์œจ์€ 68.10%์ž…๋‹ˆ๋‹ค.
๊ณผ๋Œ€ ํ‰๊ฐ€๋œ
ํšŒ์‚ฌ์˜ ์ตœ์‹  PE์€ 21.19๋กœ, ์ตœ๊ทผ 3๋…„ ๊ธฐ์ค€ ๋†’์€ ๋ฐฑ๋ถ„์œ„ ๋ฒ”์œ„์— ์†ํ•ฉ๋‹ˆ๋‹ค.
๊ธฐ๊ด€ ๋งค๋„
์ตœ์‹  ๊ธฐ๊ด€ ๋ณด์œ  ์ฃผ์‹ ์ˆ˜๋Š” 143.01M์ฃผ์ด๋ฉฐ, ์ „ ๋ถ„๊ธฐ ๋Œ€๋น„ 1.13% ๊ฐ์†Œํ–ˆ์Šต๋‹ˆ๋‹ค.
ํŠธ์œ„๋”” ๋ธŒ๋ผ์šด๊ฐ€ ๋ณด์œ 
์Šคํƒ€ ํˆฌ์ž์ž ํŠธ์œ„๋”” ๋ธŒ๋ผ์šด์ด(๊ฐ€) ์ด ์ฃผ์‹ 1.08M์ฃผ๋ฅผ ๋ณด์œ ํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

๋ถ„์„๊ฐ€ ๋ชฉํ‘œ๊ฐ€

10 ๋ช…์˜ ๋ถ„์„๊ฐ€๋ฅผ ๊ธฐ์ค€์œผ๋กœ
์œ ์ง€
ํ˜„์žฌ ๋“ฑ๊ธ‰
143.654
๋ชฉํ‘œ ๊ฐ€๊ฒฉ
-2.33%
์ƒ์Šน ์—ฌ๋ ฅ
๋ฉด์ฑ… ์กฐํ•ญ: ์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€ ๋ฐ ๋ชฉํ‘œ ์ฃผ๊ฐ€๋Š” ์ •๋ณด ์ œ๊ณต์„ ์œ„ํ•œ ๋ชฉ์ ์œผ๋กœ LSEG์—์„œ ์ œ๊ณต๋˜๋ฉฐ, ํˆฌ์ž ์กฐ์–ธ์œผ๋กœ ๊ฐ„์ฃผ๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.

Novartis AG ๋‰ด์Šค

๋” ๋งŽ์€ ๋‰ด์Šค๊ฐ€ ๊ณง ์—…๋ฐ์ดํŠธ๋ฉ๋‹ˆ๋‹ค. ๊ณ„์† ์ง€์ผœ๋ด ์ฃผ์„ธ์š”โ€ฆ

์žฌ๋ฌด ์ง€ํ‘œ๎˜

EPS

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์ด ์ˆ˜์ต

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

Novartis AG ์ •๋ณด๎˜

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
์ข…๋ชฉ ์ฝ”๋“œ NVS
ํšŒ์‚ฌNovartis AG
CEONarasimhan (Vasant)
์›น์‚ฌ์ดํŠธhttps://www.novartis.com/

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Novartis AG(NVS)์˜ ํ˜„์žฌ ๊ฐ€๊ฒฉ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Novartis AG(NVS)์˜ ํ˜„์žฌ ์ฃผ๊ฐ€๋Š” 148.94์ž…๋‹ˆ๋‹ค.

Novartis AG์˜ ์ข…๋ชฉ ๊ธฐํ˜ธ(Symbol)๋Š” ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
Novartis AG์˜ ์ข…๋ชฉ ์ฝ”๋“œ๋Š” NVS์ž…๋‹ˆ๋‹ค.

Novartis AG์˜ 52์ฃผ ์ตœ๊ณ ๊ฐ€๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Novartis AG์˜ 52์ฃผ ์ตœ๊ณ ๊ฐ€๋Š” 170.46์ž…๋‹ˆ๋‹ค.

Novartis AG์˜ 52์ฃผ ์ตœ์ €๊ฐ€๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Novartis AG์˜ 52์ฃผ ์ตœ์ €๊ฐ€๋Š” 111.06์ž…๋‹ˆ๋‹ค.

Novartis AG์˜ ์‹œ๊ฐ€์ด์•ก์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Novartis AG์˜ ์‹œ๊ฐ€์ด์•ก์€ 302.72B์ž…๋‹ˆ๋‹ค.

Novartis AG(NVS)์˜ ํ˜„์žฌ ํˆฌ์ž ๋“ฑ๊ธ‰์€ ๋งค์ˆ˜, ๋ณด์œ , ๋งค๋„ ์ค‘ ์–ด๋–ค๊ฐ€์š”?

๎™Œ
์• ๋„๋ฆฌ์ŠคํŠธ๋“ค์— ๋”ฐ๋ฅด๋ฉด, Novartis AG(NVS)๋Š” ์ „๋ฐ˜์ ์ธ ํ‰๊ฐ€์—์„œ signal_hold ๋“ฑ๊ธ‰์„ ๋ฐ›๊ณ  ์žˆ์œผ๋ฉฐ, ๋ชฉํ‘œ ์ฃผ๊ฐ€๋Š” 143.65์ž…๋‹ˆ๋‹ค.

Novartis AG(NVS)์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS TTM)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Novartis AG(NVS)์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS TTM)์€ 7.21์ž…๋‹ˆ๋‹ค.
KeyAI
๎™